Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark

Fusion Bx™ 2.0 MRI/Ultrasound fusion technology to provide targeted prostate biopsies across Europe TORONTO, CANADA – Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it has received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from multiparametric MRI (mpMRI) with a semi-robotic arm and user-friendly interface, the […]